Top Fund Managers

Latest Mutual Fund News

Financial Advisor Sponsor:Dean L. Boebinger

Bookmark this site!

(Enter Stock Symbol)

Partner Sites

Annuities
Wall Street Journal
eHealthInsurance

Fund Mojo on Facebook

Fund Mojo provides investors and financial advisors with deep financial intelligence through systematic data collection, correlation and analysis, as well as a community and gateway to connect investors with peers and financial experts to help each other with investments and financial planning needs.

Latest Financial News on NVS Stock

BloggingStocks

Before the Bell: Investors Bullish as New Year Trading Gets Underway [January 4 2010 05:30 AM]
Novartis (NVS): Big Pharma's best pipeline [July 7 2008 09:22 AM]
Earnings preview: Will Pfizer beat in Q1? [April 27 2009 06:30 AM]
Where should granny put $50,000? [October 9 2009 01:40 PM]
Health care questions (rip-off) abound -- ABT, JNJ, NVS & TEVA [August 17 2009 03:30 PM]

News for Novartis AG (ADR) - Google Finance

May need wider eczema caution for kids: FDA [March 18 2010 07:07 AM]
An Aspiring Blockbuster [March 17 2010 11:59 AM]
EU approves Novartis' meningoccal vaccine [March 17 2010 11:23 PM]
Novartis AG Gets EU Approval For Menveo As Meningococcal Vaccine-DJ [March 17 2010 11:15 PM]
Looking at Merck & Co. Inc. performance since earnings; MRK, AZN, ABT, NVS [March 16 2010 05:14 AM]

Yahoo! Finance: NVS News - Novartis AG (ADR) (NVS)

$NVS Stock - Twitter Search - Novartis AG (ADR) (NVS)

No current NVS Stock news

MSN Money News - NVS - Novartis AG (ADR) (NVS)

The New Leaders: Collaborative, Not Commanding [March 19 2010 01:59 PM]
Teva to Buy Ratiopharm [March 18 2010 05:17 PM]
Market Report -- In Play (NVS) [March 18 2010 07:32 AM]
Novartis gets Europe clearance for meningitis drug [March 18 2010 02:54 AM]
Teva Beats Pfizer to Ratiopharm [March 18 2010 10:35 AM]

Blogs on NVS Stock

Loading related blogs on NVS Stock

Mutual Funds Impacted by NVS Stock

Complete List : S&P 500 | Russell 3000 | ETF

Data is provided for informational purposes only, and is not intended for trading purposes. Although data are gathered from sources believed to be reliable, Fund Mojo and its content providers cannot guarantee completeness and accuracy. Performance data quoted represents past performance. Fund Mojo and its content providers accept no liability for reliance on this data.